5-broMo-4-chloro-7-Methyl-7H-pyrrolo[2,3-d]pyriMidine
97%
- Product Code: 49006
CAS:
1266343-30-9
| Molecular Weight: | 246.4917 g./mol | Molecular Formula: | C₇H₅BrClN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 359.5±37.0 ℃ at 760 mmHg | |
| Density: | 1.90±0.1 g/cm3 | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting kinase enzymes. Due to its structural properties, it is often incorporated into the design of inhibitors that regulate cellular signaling pathways, making it valuable in the treatment of cancers and inflammatory diseases. Additionally, its unique pyrrolopyrimidine core is explored in the development of antiviral and antimicrobial agents, contributing to the advancement of therapies for infectious diseases. Researchers also leverage its reactivity to create novel compounds for high-throughput screening in drug discovery programs.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $325.62 |
+
-
|
| 5.000 | 10-20 days | $857.94 |
+
-
|
5-broMo-4-chloro-7-Methyl-7H-pyrrolo[2,3-d]pyriMidine
This compound is primarily utilized in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting kinase enzymes. Due to its structural properties, it is often incorporated into the design of inhibitors that regulate cellular signaling pathways, making it valuable in the treatment of cancers and inflammatory diseases. Additionally, its unique pyrrolopyrimidine core is explored in the development of antiviral and antimicrobial agents, contributing to the advancement of therapies for infectious diseases. Researchers also leverage its reactivity to create novel compounds for high-throughput screening in drug discovery programs.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :